Evidence map›Paper›PMID 32855512›Full record

ReviewPediatric research2020

Grading the evidence to identify strategies to modify risk for necrotizing enterocolitis.

Sheila M Gephart, Mark A Underwood, Simone Rosito, Jae H Kim, Michael S Caplan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 4 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 4 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Sheila M GephartCollege of Nursing, University of Arizona, Tucson, AZ, USA. gepharts@email.arizona.edu.
Mark A UnderwoodDepartment of Pediatrics, University of California, Davis, Sacramento, CA, USA.
Simone RositoInstituto PGG (Pequenos Grandes Guerreiros), Sao Paulo, Brazil.
Jae H KimCincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Michael S CaplanDepartment of Pediatrics, Northshore Research Institute, Chicago, IL, USA.
Cincinnati Children's Hospital Medical Center · USNorthShore University HealthSystem · USUniversity of Arizona · USUniversity of California, Davis · US

Funding

Clinical decision support optimizing NEC prevention implementation in NICUK08HS022908 · AHRQ · UNIVERSITY OF ARIZONA · PI GEPHART, SHEILA MARIA · 2014 to 2018
$696k
AHRQ HHS K08 HS022908
6 · The paper itself

Abstract

Although risk for necrotizing enterocolitis (NEC) is often presented from the perspective of a premature infant's vulnerability to nonmodifiable risk factors, in this paper we describe the evidence and present recommendations to manage modifiable risks that are amenable to clinical actions. Using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria, we present recommendations in the context of their supporting evidence in a way that balances risks (e.g. potential harm, cost) and benefits. Across the prenatal, intrapartum, early and late clinical course, strategies to limit NEC risk in premature infants are presented. Our goal is to summarize modifiable NEC risk factors, grade the evidence to offer quality improvement (QI) targets for healthcare teams and offer a patient-family advocate's perspective on how to engage parents to recognize and reduce NEC risk.

Indexed as

Severity of Illness IndexAdrenal Cortex HormonesAnemiaAnti-Bacterial AgentsDuctus Arteriosus, PatentEnterocolitis, NecrotizingFemaleHumansIndomethacinInfantInfant, NewbornIntensive Care, NeonatalIntensive Care Units, NeonatalLactationMilk, HumanProbioticsAdrenal Cortex HormonesAnti-Bacterial AgentsIndomethacin

Identifiers

PMID32855512
OpenAlexW3082975922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.